🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ariana Huebner

The Francis Crick Institute

ORCID: 0000-0001-8009-4999

Also affiliated with Cancer Research UK, London Cancer, CRUK Lung Cancer Centre of Excellence, University College London

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.5Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

Nature Medicine(2023)10.1038/s41591-023-02230-w
Top 9%
2.5DataRank
Top 9%105 citations

David A. Moore, Selvaraju Veeriah, Cristina Naceur‐Lombardelli, Antonia Toncheva, Neil Magno +93 more

Papers

Driven by 8 papers — median percentile 91. Top paper: “Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA”.

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

Nature(2023)10.1038/s41586-023-05776-4
N/A
5.3DataRank · unranked
350 citations

Alexander M. Frankell, Thomas Harrison, Judit Kisistók, Aaron T. Garnett, Laura Johnson +95 more

Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

Nature Medicine(2023)10.1038/s41591-023-02230-w
Top 9%
2.5DataRank
Top 9%105 citations

David A. Moore, Selvaraju Veeriah, Cristina Naceur‐Lombardelli, Antonia Toncheva, Neil Magno +93 more

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

Cancer Cell(2021)10.1016/j.ccell.2021.10.001
N/A
0.838DataRank · unranked
265 citations

Emine Hatipoglu, Marc Robert de Massy, Kevin Litchfield, Gordon Beattie, Andrew Rowan +93 more

Body composition and lung cancer-associated cachexia in TRACERx

Nature Medicine(2023)10.1038/s41591-023-02232-8
N/A
0.738DataRank · unranked
136 citations

Jakob Weiss, Marcin Skrzypski, Jie Min Lam, Takahiro Karasaki, Francisco Zambrana +92 more

MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

Nature Genetics(2024)10.1038/s41588-024-01883-8
N/A
0.561DataRank · unranked
41 citations

Thomas P. Jones, Michelle Leung, Felipe Gálvez‐Cancino, Jiali Liu, Manuel Varas‐Godoy +87 more

Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma

Nature Cancer(2025)10.1038/s43018-024-00883-1
N/A
0.456DataRank · unranked
13 citations

Yun-Hsin Liu, Javier Herrero, Yin Wu, David A. Moore, Takahiro Karasaki +95 more

A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis

Science Translational Medicine(2025)10.1126/scitranslmed.adu2459
N/A
0.292DataRank · unranked
6 citations

Kui Zhai, Nikoo Aghaei, Petar Miletic, Zhi Huang, Kevin R. Brown +35 more

Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.16.572007
N/A
0DataRank · unranked
3 citations

Richard Edwards, Will E. Tyrrell, Abigail R. Barber, Friedrich Baark, Muhammet Tanç +16 more